Acme United Corporation ACU R2K
Company Overview
Acme United Corporation supplies cutting, measuring, first aid, and sharpening products to the school, home, office, hardware, sporting goods, and industrial markets in the United States, Canada, Europe, and internationally. The company offers scissors, shears, knives, rulers, pencil sharpeners, paper trimmers, safety cutters, lettering products, glue guns, and other craft products under the Westcott brand name; and cutting tools under the Clauss brand. It also provides sharpening knives, scissors, chisels, skis, skates, and other edges under the DMT brand. In addition, the company offers first aid kits and safety solutions under the First Aid Only brand; portable eyewash solution and over-the-counter medication, including active ingredients aspirin, acetaminophen, and ibuprofen under the PhysiciansCare brand; bodily fluid and spill clean-up solution under the Spill Magic brand; various first aid kit, refill, and safety supplies, including CPR kits, burn kits, and automotive and emergency first aid kits under the First Aid Central; first aid kits for the promotional products industry under Safety Made brand; alcohol prep pads, alcohol wipes, benzalkonium chloride wipes, various antiseptic wipes under the Med-Nap brand, and Pac-Kit, as well as My Medic brands. It sells its products directly and through its independent manufacturer representatives to wholesale, contract, and retail stationery distributors; office supply superstores, mass market retailers, industrial and medical distributors, school supply distributors, drug store retailers, sporting goods stores, hardware chains, and wholesale florists, as well as through its websites. The company was formerly known as Acme Shear Company and changed its name to Acme United Corporation in 1971. Acme United Corporation was founded in 1867 and is based in Shelton, Connecticut.
Why Investors Should Care
Net profit has compounded at 49.7% per year over the last five years.
Carries low leverage with a debt-to-equity ratio of 0.32.
Generates positive free cash flow, funding growth and shareholder returns internally.
Recent Developments
- Dec 2025 Revenue of $196.54M (+1.1% YoY); net profit $10.18M.
- Trailing 12 Months Year-on-year growth — revenue +16.1%, earnings +5.2%.
- 5-Year Trend Long-term compounding — revenue CAGR 0.4%, profit CAGR 49.7%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 0.44% |
| 1 Year: | 16.10% |
Compounded Profit Growth
| 5 Years: | 49.72% |
| 1 Year: | 5.20% |
Stock Price Performance
| 1 Year: | +43.75% |
| 6 Months: | +49.59% |
| 3 Months: | +44.86% |
| 1 Month: | +12.41% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMAAbove
- Price vs 200-DMAAbove
- RSI (14)65.38 · Neutral
P/E of 26.53 is above the sector median of 18.74 — pricier than peers.
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Profit CAGR of 49.7% over 5 years.
- Generates positive free cash flow.
- In a confirmed uptrend (50-DMA above 200-DMA).
CONS
No notable concerns flagged.
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Peer comparison
Peer companies in the same sector (Consumer Defensive).
| # | Name | CMP $ | P/E | Mkt Cap | Div Yld % | ROCE % | ROE % | Rev CAGR 5Y % | Profit CAGR 5Y % |
|---|---|---|---|---|---|---|---|---|---|
| 1 | ACU Acme United Corporation R2K | 63.14 | 26.53 | $242.07M | 1.06% | 9.91% | 8.35% | 0.44% | 49.72% |
| 2 | WMT Walmart Inc. SPXR3K | 107.14 | 37.73 | $852.63B | 0.88% | 16.83% | 24.13% | 3.82% | 3.24% |
| 3 | COST Costco Wholesale Corporation NDXSPXR3K | 915.74 | 46.16 | $406.11B | 0.62% | 25.96% | 29.15% | 8.16% | 11.45% |
| 4 | KO The Coca-Cola Company SPXR3K | 88.07 | 26.45 | $378.93B | 2.44% | 16.47% | 42.05% | 2.86% | 4.46% |
| 5 | PG The Procter & Gamble Company SPXR3K | 146.44 | 22.32 | $341.00B | 2.96% | 22.49% | 30.29% | 0.52% | 1.59% |
| 6 | PM Philip Morris International Inc. SPXR3K | 182.53 | 25.07 | $284.49B | 3.13% | 34.03% | -113.55% | -1.69% | 3.57% |
| 7 | PEP PepsiCo, Inc. NDXSPXR3K | 137.63 | 18.04 | $188.00B | 4.28% | 15.41% | 51.51% | 4.93% | 2.11% |
| 8 | BUD Anheuser-Busch InBev SA/NV | 80.35 | 17.32 | $140.40B | 1.61% | 8.49% | 11.39% | 0.88% | 4.63% |
| 9 | MO Altria Group, Inc. SPXR3K | 68.88 | 14.50 | $115.01B | 6.26% | 38.27% | - | 1.24% | -1.89% |
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Jun 2015 | Sep 2015 | Dec 2015 | Mar 2016 | Jun 2016 | Sep 2016 | Dec 2016 | Mar 2017 | Jun 2017 | Sep 2017 | Dec 2017 | Mar 2018 | Jun 2018 | Sep 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sep 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sep 2020 | Mar 2021 | Jun 2021 | Sep 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | 27.75M | 38.85M | 33.78M | 30.17M | 31.71M | 39.75M | 34.73M | 31.13M | 31.37M | 40.22M | 36.99M | 33.87M | 35.77M | 44.04M | 43.32M | 43.52M | 44.85M | 47.92M | 43.33M | 56.77M | 49.74M | 45.84M | 53.34M | 50.38M | 44.96M | 55.42M | - | - | 45.96M | 54.00M | 49.06M | 47.52M | 52.30M |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 28.04M | 31.85M | 29.87M | 29.38M | 31.52M |
| Gross Profit | 12.54M | 10.32M | - | 9.19M | 14.70M | 11.86M | 9.81M | 10.56M | 14.48M | 12.23M | 10.63M | 12.12M | 14.71M | 12.45M | 11.36M | 11.80M | 14.77M | 13.13M | 12.29M | 13.53M | 16.05M | 14.96M | 15.59M | 16.15M | 17.00M | 14.97M | 18.55M | 15.93M | 16.28M | 20.02M | 19.50M | 17.40M | 22.63M | - | - | 17.92M | 22.15M | 19.20M | 18.15M | 20.79M |
| Operating Expenses | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 15.49M | 15.76M | 16.19M | 15.25M | 19.04M |
| Operating Income | 3.88M | 1.99M | - | 955.00K | 4.64M | 2.14M | - | 1.21M | 3.91M | 1.97M | - | 1.36M | 3.62M | 1.37M | - | 1.53M | 3.77M | 1.73M | - | 2.01M | 4.38M | 2.12M | 2.97M | 3.79M | 2.96M | 1.37M | 3.98M | 953.00K | 2.19M | 5.25M | 3.66M | 2.56M | 6.38M | - | - | 2.43M | 6.39M | 3.01M | 2.90M | 1.75M |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 4.02M | 8.04M | 4.50M | 4.44M | 3.70M |
| Interest Expense | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 397.00K | 430.00K | 451.00K | 249.92K | 486.00K |
| Pretax Income | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 2.12M | 6.09M | 2.44M | 2.47M | 1.24M |
| Tax Provision | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 466.00K | 1.34M | 536.00K | 595.20K | 259.00K |
| Net Income | 2.71M | 1.21M | 440.00K | 565.00K | 3.27M | 1.47M | 545.00K | 659.00K | 2.85M | 1.20M | -655.00K | 764.00K | 2.44M | 807.00K | 591.00K | 807.00K | 2.67M | 1.06M | 978.00K | 1.28M | 3.20M | 1.58M | 2.05M | 7.23M | 2.05M | 830.00K | 2.74M | 64.00K | 990.00K | 3.44M | 2.15M | 1.64M | 4.45M | - | - | 1.65M | 4.75M | 1.90M | 1.88M | 985.00K |
| Diluted EPS | 0.74 | 0.33 | 0.11 | 0.16 | 0.91 | 0.40 | 0.15 | 0.18 | 0.75 | 0.32 | -0.16 | 0.21 | 0.67 | 0.23 | 0.17 | 0.24 | 0.77 | 0.30 | 0.29 | 0.36 | 0.92 | 0.46 | 0.52 | 1.82 | 0.50 | 0.22 | 0.71 | 0.02 | 0.28 | 0.96 | 0.58 | 0.39 | 1.09 | - | - | 0.41 | 1.16 | 0.46 | 0.46 | 0.24 |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 63.15M | 73.30M | 84.37M | 89.58M | 107.22M | 109.81M | 124.57M | 130.55M | 137.32M | 142.46M | 164.00M | - | 193.96M | 191.50M | 194.49M | 196.54M |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | 130.40M | 119.29M | 118.14M | 119.13M |
| Gross Profit | 23.37M | 26.32M | 29.75M | 31.82M | 38.19M | 39.56M | 45.56M | 47.90M | 50.65M | 52.00M | 59.59M | - | 63.56M | 72.21M | 76.35M | 77.41M |
| Operating Expenses | - | - | - | - | - | - | - | - | - | - | - | - | 57.29M | 59.02M | 62.21M | 62.69M |
| Operating Income | 2.98M | 4.28M | 5.36M | 5.88M | 7.39M | 7.35M | 8.44M | 7.88M | 7.46M | 8.43M | 11.41M | - | 6.27M | 13.19M | 14.14M | 14.72M |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | 10.64M | 30.90M | 20.30M | 21.02M |
| Interest Expense | - | - | - | - | - | - | - | - | - | - | - | - | 2.40M | 3.10M | 1.94M | 1.56M |
| Pretax Income | - | - | - | - | - | - | - | - | - | - | - | - | 3.66M | 22.73M | 12.29M | 13.12M |
| Tax Provision | - | - | - | - | - | - | - | - | - | - | - | - | 627.68K | 4.94M | 2.27M | 2.93M |
| Net Income | 2.57M | 2.81M | 3.55M | 4.00M | 4.79M | 4.79M | 5.85M | 4.05M | 4.60M | 5.51M | 8.10M | - | 3.03M | 17.79M | 10.02M | 10.18M |
| Diluted EPS | 0.81 | 0.91 | 1.13 | 1.22 | 1.36 | 1.30 | 1.64 | 1.09 | 1.30 | 1.60 | 2.31 | - | 0.82 | 4.86 | 2.45 | 2.49 |
| R&D Expense | - | 535.50K | 572.99K | 602.99K | 665.00K | 690.00K | 750.00K | 752.00K | 734.00K | 596.00K | 251.00K | - | - | - | - | - |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2009 | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | - | 49.58M | 55.22M | 67.83M | 68.08M | 79.31M | 81.42M | 92.07M | 114.73M | 109.48M | 110.75M | 129.87M | - | 164.38M | 149.24M | 162.17M | 171.00M |
| Current Assets | - | - | - | - | - | - | - | - | - | - | - | - | - | 105.60M | 92.02M | 95.46M | 96.20M |
| Cash & Equivalents | 6.52M | 6.60M | 7.85M | 9.75M | 11.64M | 2.29M | 2.43M | 5.91M | 9.34M | 4.41M | 6.82M | 4.17M | - | 6.10M | 4.80M | 6.40M | 3.60M |
| Inventory | - | - | - | - | - | - | - | - | - | - | - | - | - | 63.33M | 55.47M | 56.25M | 59.85M |
| Receivables | - | - | - | - | - | - | - | - | - | - | - | - | - | 32.60M | 26.23M | 28.24M | 29.10M |
| Total Liabilities | - | 24.23M | 27.45M | 36.96M | 33.07M | 39.88M | 38.24M | 45.95M | 64.79M | 57.15M | 55.04M | 67.15M | - | 85.35M | 51.34M | 55.19M | 53.39M |
| Current Liabilities | - | 9.22M | 8.70M | 11.73M | 9.88M | 15.36M | 11.94M | 12.82M | 16.78M | 13.36M | 16.58M | 20.20M | - | 22.13M | 26.01M | 22.87M | 22.87M |
| Long Term Debt | - | 13.52M | 17.57M | 24.32M | 22.91M | 24.15M | 25.91M | 32.94M | 43.45M | 40.28M | 33.24M | 38.77M | - | 60.61M | 23.39M | 27.47M | 21.28M |
| Total Debt | - | - | - | - | - | - | - | - | - | - | - | - | - | 63.83M | 25.93M | 32.84M | 28.72M |
| Total Equity | 24.54M | 25.35M | 27.77M | 30.87M | 35.01M | 39.43M | 43.18M | 46.12M | 49.94M | 52.33M | 55.70M | 62.72M | - | 79.03M | 97.90M | 106.98M | 117.61M |
| Shares Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | 5.08M | 5.19M | 5.30M | 5.35M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -1.14M | 2.06M | -1.27M | 6.48M | 4.65M | 1.08M | 8.86M | 4.81M | 4.48M | 14.70M | 5.72M | - | 2.89M | 28.90M | 11.98M | 18.23M |
| Investing Cash Flow | -1.05M | -4.17M | -2.29M | -2.97M | -15.19M | -1.91M | -8.81M | -14.38M | -3.23M | -1.68M | -13.95M | - | -14.23M | 7.43M | -12.94M | -12.30M |
| Financing Cash Flow | 2.31M | 3.43M | 5.39M | -1.61M | 1.31M | 1.14M | 3.47M | 12.91M | -6.05M | -10.61M | 5.29M | - | 14.28M | -38.44M | 2.00M | -8.88M |
| Capital Expenditure | -937.08K | -940.71K | -681.13K | -4.59M | -2.04M | -1.76M | -1.81M | -3.15M | -2.85M | -1.68M | -2.57M | - | -4.60M | -4.98M | -7.15M | -10.65M |
| Free Cash Flow | -2.07M | 1.12M | -1.95M | 1.88M | 2.61M | -676.99K | 7.05M | 1.66M | 1.62M | 13.02M | 3.15M | - | -1.71M | 23.92M | 4.83M | 7.58M |
| Net Change in Cash | - | - | - | - | - | - | - | - | - | - | - | - | 2.94M | -2.11M | 1.04M | -2.96M |
| Dividends Paid | 655.83K | 771.58K | 1.09M | 728.39K | 1.06M | 1.20M | 1.33M | 1.41M | 1.48M | 1.61M | 1.60M | 1.79M | 1.90M | 1.99M | 2.22M | 2.34M |
Ratios (Annual)
Figures in %.
| Metric | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin % | 37.0% | 35.9% | 35.3% | 35.5% | 35.6% | 36.0% | 36.6% | 36.7% | 36.9% | 36.5% | 36.3% | - | 32.8% | 37.7% | 39.3% | 39.4% |
| Operating Margin % | 4.7% | 5.8% | 6.4% | 6.6% | 6.9% | 6.7% | 6.8% | 6.0% | 5.4% | 5.9% | 7.0% | - | 3.2% | 6.9% | 7.3% | 7.5% |
| Net Margin % | 4.1% | 3.8% | 4.2% | 4.5% | 4.5% | 4.4% | 4.7% | 3.1% | 3.3% | 3.9% | 4.9% | - | 1.6% | 9.3% | 5.2% | 5.2% |
| ROE % | 10.1% | 10.1% | 11.5% | 11.4% | 12.1% | 11.1% | 12.7% | 8.1% | 8.8% | 9.9% | 12.9% | - | 3.8% | 18.2% | 9.4% | 8.7% |
| ROCE % | 7.4% | 9.2% | 9.6% | 10.1% | 11.6% | 10.6% | 10.7% | 8.0% | 7.8% | 9.0% | 10.4% | - | 4.4% | 10.7% | 10.2% | 9.9% |
Shareholding Pattern
Top Institutional Holders
| # | Holder | % Held | Shares | Value |
|---|---|---|---|---|
| 1 | Capital Management Corporation | 12.44% | 474.15K | $29.90M |
| 2 | Mink Brook Asset Management LLC | 9.99% | 380.64K | $24.00M |
| 3 | North Star Investment Management Corp | 6.50% | 247.65K | $15.62M |
| 4 | Blackrock Inc. | 4.72% | 179.76K | $11.34M |
| 5 | Dimensional Fund Advisors LP | 4.65% | 177.13K | $11.17M |
| 6 | Royce & Associates LP | 3.84% | 146.40K | $9.23M |
| 7 | Vanguard Capital Management LLC | 3.81% | 145.12K | $9.15M |
| 8 | Renaissance Technologies, LLC | 2.88% | 109.61K | $6.91M |
| 9 | Bard Associates Inc. | 2.84% | 108.19K | $6.82M |
| 10 | Geode Capital Management, LLC | 2.20% | 83.81K | $5.29M |
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for ACU
Is Acme United (ACU) a Solid Growth Stock? 3 Reasons to Think "Yes"
Acme United (ACU) possesses solid growth attributes, which could help it handily outperform the market.
Is Acme United (ACU) Outperforming Other Consumer Discretionary Stocks This Year?
Here is how Acme United Corporation. (ACU) and ASICS Corporation Unsponsored ADR (ASCCY) have performed compared to their sector so far this year.
Acme United (ACU) is an Incredible Growth Stock: 3 Reasons Why
Acme United (ACU) possesses solid growth attributes, which could help it handily outperform the market.
Acme United’s Westcott® Brand Celebrates National Scissors Day™ on August 1st, 2026
SHELTON, Conn., July 30, 2026 (GLOBE NEWSWIRE) -- Acme United Corporation (NYSE, American: ACU), a global leader in cutting tools, and school, home and office products, is proud to celebrate the second annual National Scissors Day™, August …
Acme United (ACU) Q2 2026 Earnings Call Transcript
MyMedic acquisition drives record revenue as healthcare now comprises 70% of sales.
Acme United Corp (ACU) Q2 2026 Earnings Call Highlights: Strong Sales Growth Amid Economic ...
Acme United Corp (ACU) reports a 16% increase in net sales and improved gross margins, despite facing high inflation and supply chain disruptions.
ACU — Frequently Asked Questions
What is the current share price of Acme United Corporation (ACU)?
As of 2026-09-07 16:24 PDT, Acme United Corporation (ACU) trades at $63.14 on NYSE American. Its 52-week range is $35.12 to $63.82.
What is the market capitalisation of ACU?
Acme United Corporation (ACU) has a market capitalisation of $242.07M on NYSE American.
What is the P/E ratio of ACU?
ACU trades at a trailing price-to-earnings (P/E) ratio of 26.53. The industry average P/E is 18.74. Its price-to-book (P/B) ratio is 1.91.
Does ACU pay a dividend?
Acme United Corporation (ACU) currently offers a dividend yield of 1.06%.
What is the return on equity (ROE) of ACU?
ACU has a return on equity (ROE) of 8.35%. Its return on capital employed (ROCE) is 9.91%.
Is ACU a good stock to buy?
This page provides a data-driven analysis of Acme United Corporation (ACU), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.